BioBridgeXAll companies

Longeveron Inc.

Pharmaceutical company · Miami, Florida, United States · Nasdaq: LGVN

Longeveron Inc. is a pharmaceutical company headquartered in Miami, Florida, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker LGVN. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $5.2 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $16 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Longeveron at a glance

Typepharmaceutical company
HeadquartersMiami, Florida, United States
Earliest incorporation on record2014
Stock listingNasdaq: LGVN
SEC industryPharmaceutical Preparations
Employees (per SBIR records)10
SEC CIK1721484

What does Longeveron do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $5.2 million in total (2017 to 2019). NIH funding came from the National Institute on Aging.

Private fundraising reported to the SEC

11 Form D notices; the most recent reported $15.9 million sold (2026).

Frequently asked questions about Longeveron

Where is Longeveron headquartered?

Longeveron Inc. is headquartered in Miami, Florida, United States.

What does Longeveron do?

Longeveron Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Longeveron a public company?

Yes. Longeveron Inc. trades on Nasdaq under the ticker LGVN.

When was Longeveron founded?

The earliest incorporation on record for Longeveron Inc. is in 2014, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.